149 related articles for article (PubMed ID: 36896074)
1. Incorporating the epidermal growth factor receptor expression and histopathological parameters in a mathematical model to predict the prognosis of oral squamous cell carcinoma: a prospective observational cohort study.
Akheel M; Senthilmurugan M; Jain A; Chahwala Q; Sherlin HJ; Wadhwania A
J Maxillofac Oral Surg; 2022 Dec; 21(4):1065-1073. PubMed ID: 36896074
[TBL] [Abstract][Full Text] [Related]
2. Association of Surgical Margins and Pathological Staging with Epidermal Growth Factor Receptor Expression in Oral Squamous Cell Carcinoma- A Prospective Cohort Study.
Akheel M; Senthilmurugan M; Sherlin HJ; Jain A; Chahwala Q; Wadhwania A
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):6001-6006. PubMed ID: 36742945
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of depth of invasion and tumor size on risk of neck node metastasis in squamous cell carcinoma of the oral cavity: A prospective study.
Jangir NK; Singh A; Jain P; Khemka S
J Cancer Res Ther; 2022; 18(4):977-983. PubMed ID: 36149149
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Cyclin D1 and Human Epidermal Growth Factor Receptor 2 Neu Protein Expression in Head and Neck Squamous Cell Carcinoma.
Sinha S; Das S; Mohiyuddin SMA
Cureus; 2023 Feb; 15(2):e35526. PubMed ID: 37007344
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.
Gao J; Ulekleiv CH; Halstensen TS
J Exp Clin Cancer Res; 2016 Sep; 35(1):151. PubMed ID: 27669890
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
[TBL] [Abstract][Full Text] [Related]
8. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2/neu, p53, and Ki67 in oral squamous cell carcinoma.
Mohanapure NS; Khandeparkar SGS; Saragade PB; Gogate BP; Joshi AR; Mehta SR
J Oral Maxillofac Pathol; 2022; 26(1):127-128. PubMed ID: 35571320
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer.
Zanotti L; Paderno A; Piazza C; Pagan E; Bignotti E; Romani C; Bandiera E; Calza S; Del Bon F; Nicolai P; Ravaggi A
Laryngoscope; 2017 Nov; 127(11):E408-E414. PubMed ID: 28782189
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Histomorphological Parameters to Predict Occult Nodal Metastasis in Early-Stage Oral Squamous Cell Carcinoma.
Verma R; Singh A; Chowdhury N; Joshi PP; Durgapal P; Rao S; Kishore S
Turk Patoloji Derg; 2022; 38(3):227-234. PubMed ID: 34978064
[TBL] [Abstract][Full Text] [Related]
12. Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression.
Vadla P; Deepthi G; Julakanti V; Jahagirdar D; Meruva S; Tantravahi S
J Contemp Dent Pract; 2022 May; 23(5):497-502. PubMed ID: 35986456
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis.
Sarkis SA; Abdullah BH; Abdul Majeed BA; Talabani NG
Head Neck Oncol; 2010 Jun; 2():13. PubMed ID: 20579333
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
15. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
16. Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.
Wedemeyer I; Kreppel M; Scheer M; Zöller JE; Büttner R; Drebber U
Oral Dis; 2014 Apr; 20(3):e81-9. PubMed ID: 23746299
[TBL] [Abstract][Full Text] [Related]
17. Assessment of epidermal growth factor receptor in histological, clinical and pathological staging of oral squamous cell carcinoma.
Umarani PJ; Rudresh KB; Smitha T; Rajaram P
J Oral Maxillofac Pathol; 2022; 26(3):362-365. PubMed ID: 36588836
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Pattern of Invasion, Stromal Inflammation and Lymphovascular Invasion With Histopathological Grading in Oral Squamous Cell Carcinoma: A Retrospective Study.
Khan SJ; Gawande M; Hande AH; Patil SK; Sonone AM
Cureus; 2024 Jan; 16(1):e52233. PubMed ID: 38352087
[TBL] [Abstract][Full Text] [Related]
19. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
[TBL] [Abstract][Full Text] [Related]
20. Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance.
Kanemaru A; Shinriki S; Kai M; Tsurekawa K; Ozeki K; Uchino S; Suenaga N; Yonemaru K; Miyake S; Masuda T; Kariya R; Okada S; Takeshita H; Seki Y; Yano H; Komohara Y; Yoshida R; Nakayama H; Li JD; Saito H; Jono H
Cancer Cell Int; 2022 Nov; 22(1):358. PubMed ID: 36376983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
